Kineta Inc (KA)
0.4424
-0.04
(-9.16%)
USD |
NASDAQ |
May 17, 16:00
0.4424
0.00 (0.00%)
After-Hours: 20:00
Kineta Cash from Financing (Quarterly): 2.246M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.246M |
| September 30, 2023 | -0.007M |
| June 30, 2023 | 5.479M |
| March 31, 2023 | 0.75M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.591M |
| September 30, 2022 | 1.426M |
| June 30, 2022 | 3.30M |
| March 31, 2022 | -1.509M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.509M
Minimum
Mar 2022
8.591M
Maximum
Dec 2022
2.534M
Average
1.836M
Median
Cash from Financing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | -15.56M |
| Ampio Pharmaceuticals Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.075M |
| Free Cash Flow | -16.21M |
| Free Cash Flow Per Share (Quarterly) | -0.3208 |
| Free Cash Flow Yield | -335.6% |